Analysts Set Phibro Animal Health Corp (NASDAQ:PAHC) Price Target at $40.33

Phibro Animal Health Corp (NASDAQ:PAHC) has been given an average recommendation of “Hold” by the seven research firms that are currently covering the stock, Marketbeat reports. Two equities research analysts have rated the stock with a sell recommendation, three have given a hold recommendation and two have given a buy recommendation to the company. The average 1 year price objective among brokers that have issued a report on the stock in the last year is $37.67.

Several equities analysts have recently issued reports on PAHC shares. Zacks Investment Research upgraded Phibro Animal Health from a “sell” rating to a “hold” rating in a research report on Monday, April 29th. Guggenheim started coverage on Phibro Animal Health in a research report on Thursday, May 23rd. They set a “neutral” rating for the company. ValuEngine downgraded Phibro Animal Health from a “hold” rating to a “sell” rating in a research report on Wednesday, May 8th. Barclays started coverage on Phibro Animal Health in a research report on Tuesday. They set an “underweight” rating and a $25.00 price objective for the company. Finally, BidaskClub upgraded Phibro Animal Health from a “hold” rating to a “buy” rating in a research report on Tuesday, May 7th.

Several hedge funds and other institutional investors have recently modified their holdings of the company. FMR LLC boosted its holdings in Phibro Animal Health by 82.7% in the first quarter. FMR LLC now owns 337,652 shares of the company’s stock worth $11,143,000 after purchasing an additional 152,853 shares in the last quarter. Zebra Capital Management LLC boosted its holdings in Phibro Animal Health by 9.4% during the first quarter. Zebra Capital Management LLC now owns 7,059 shares of the company’s stock valued at $233,000 after acquiring an additional 604 shares during the period. Morgan Stanley boosted its holdings in Phibro Animal Health by 83.7% during the first quarter. Morgan Stanley now owns 226,799 shares of the company’s stock valued at $7,485,000 after acquiring an additional 103,345 shares during the period. Man Group plc boosted its holdings in Phibro Animal Health by 12.2% during the first quarter. Man Group plc now owns 177,158 shares of the company’s stock valued at $5,846,000 after acquiring an additional 19,200 shares during the period. Finally, Advisors Asset Management Inc. boosted its holdings in Phibro Animal Health by 136.0% during the first quarter. Advisors Asset Management Inc. now owns 5,984 shares of the company’s stock valued at $197,000 after acquiring an additional 3,448 shares during the period. Institutional investors and hedge funds own 50.25% of the company’s stock.

Shares of PAHC stock opened at $29.18 on Tuesday. The company has a debt-to-equity ratio of 1.48, a current ratio of 3.41 and a quick ratio of 1.98. Phibro Animal Health has a 52 week low of $27.32 and a 52 week high of $54.62. The company has a market capitalization of $1.19 billion, a price-to-earnings ratio of 16.77, a P/E/G ratio of 4.37 and a beta of 0.74.

Phibro Animal Health (NASDAQ:PAHC) last issued its earnings results on Monday, May 6th. The company reported $0.39 EPS for the quarter, missing the Zacks’ consensus estimate of $0.43 by ($0.04). Phibro Animal Health had a net margin of 8.12% and a return on equity of 33.77%. The company had revenue of $205.70 million during the quarter, compared to analyst estimates of $214.94 million. During the same quarter in the previous year, the firm earned $0.46 earnings per share. The business’s revenue was down 1.5% on a year-over-year basis. On average, analysts predict that Phibro Animal Health will post 1.52 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 26th. Stockholders of record on Wednesday, June 5th will be given a dividend of $0.12 per share. The ex-dividend date is Tuesday, June 4th. This represents a $0.48 annualized dividend and a dividend yield of 1.64%. Phibro Animal Health’s dividend payout ratio is presently 27.59%.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture.

Read More: Cost of equity and a company’s balance sheet

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit